Trial watch: Monoclonal antibodies in cancer therapy

During the past 20 years, dozens—if not hundreds—of monoclonal antibodies have been developed and characterized for their capacity to mediate antineoplastic effects, either as they activate/enhance tumor-specific immune responses, either as they interrupt cancer cell-intrinsic signal transduction ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacchelli, Erika, Eggermont, Alexander, Galon, Jérôme, Sautès-Fridman, Catherine, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583934/
https://www.ncbi.nlm.nih.gov/pubmed/23482847
http://dx.doi.org/10.4161/onci.22789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583934/
https://www.ncbi.nlm.nih.gov/pubmed/23482847
http://dx.doi.org/10.4161/onci.22789

Ejemplares similares